MRC Epidemiology Unit

 

A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.

Waterworth DM, Li L, Scott RA, Warren L, Gillson C, Aponte J, Sarov-Blat L, Sprecher D, Dupuis J, Reiner A, Psaty BM, Tracy RP, Lin H, McPherson R, Chissoe S, Wareham NJ, Ehm MG

Journal of the American Heart Association. Aug 2014

(DOI : 10.1161/JAHA.114.001074)

---